Landos Biopharma raises $10M in series A funding round — 3 insights

Landos Biopharma completed a series A financing round raising $10 million.

Here's what you should know:

1. Perceptive Advisors led the financing round, serving as the exclusive investor.

2. Landos is a pharmaceutical pipeline developing treatments for autoimmune diseases, specifically for Crohn's disease and ulcerative colitis.

3. The funding will be used to advance the development of BT-11, specifically to advance the product through its initial phase I clinical testing.

More articles on gastroenterology: 
GI leader to know: Dr. Daryl M. McClendon of Alaska Digestive and Liver Disease Clinic
12 statistics on gastroenterologist salary — $357k is median
Penn State College of Medicine taps Dr. Thomas Ma for chairmanship — 4 key notes

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months